The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.
We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine ...
Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...
We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...
The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...
Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 ...
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...
The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine. The financial package will fund the expansion of ...